- About 170 million people globally live with age-related macular degeneration (AMD)
- About 15% of all AMD cases are wet AMD, which is a more severe form of the disease.
- Researchers report that one commonly used wet AMD drug outperformed another drug when it comes to helping people safely wean from treatment without further vision loss.
About
Advanced AMD is considered the leading cause of visual impairment and irreversible blindness globally.
Of the two types of AMD — wet and dry — about
Now, researchers from the Wilmer Eye Institute at the Johns Hopkins University School of Medicine in Maryland report that one commonly used wet AMD drug outperformed another drug when it comes to helping people safely wean from treatment without further vision loss.
The study was recently published in The Journal of Clinical Investigation.
AMD occurs when the
Most people with AMD will have dry AMD, where deposits called
Wet AMD occurs when abnormal blood vessels begin to grow in the back of the eye. These vessels can leak lipids, damaging the macula and retina.
Symptoms of wet AMD include:
- blurred vision
- reduced central vision
- straight lines that appear wavy or bent
- dark or blind areas in your vision
- need for brighter light to read
Risk factors for developing AMD include:
There are currently no therapies that can reverse either type of AMD. However, there are ways doctors can help slow the progression of the disease.
Currently, there are two main medications doctors use to help slow the progression of…
Read the full article here